Capital World Investors’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-253,000
Closed -$10M 550
2022
Q4
$10M Hold
253,000
﹤0.01% 484
2022
Q3
$11.8M Hold
253,000
﹤0.01% 485
2022
Q2
$11.1M Hold
253,000
﹤0.01% 492
2022
Q1
$18.3M Hold
253,000
﹤0.01% 498
2021
Q4
$20.5M Hold
253,000
﹤0.01% 525
2021
Q3
$29.4M Hold
253,000
0.01% 503
2021
Q2
$41.9M Hold
253,000
0.01% 469
2021
Q1
$35.3M Buy
253,000
+93,000
+58% +$15.2M 0.01% 470
2020
Q4
$27.7M Hold
160,000
0.01% 471
2020
Q3
$22.3M Hold
160,000
﹤0.01% 458
2020
Q2
$19.1M Hold
160,000
﹤0.01% 440
2020
Q1
$16M Hold
160,000
﹤0.01% 416
2019
Q4
$18.8M Hold
160,000
﹤0.01% 431
2019
Q3
$13.8M Hold
160,000
﹤0.01% 447
2019
Q2
$10.4M Hold
160,000
﹤0.01% 486
2019
Q1
$10M Hold
160,000
﹤0.01% 483
2018
Q4
$6.22M Hold
160,000
﹤0.01% 490
2018
Q3
$9.12M Hold
160,000
﹤0.01% 517
2018
Q2
$12.8M Hold
160,000
﹤0.01% 489
2018
Q1
$13.9M Hold
160,000
﹤0.01% 458
2017
Q4
$11M Hold
160,000
﹤0.01% 465
2017
Q3
$14.5M Hold
160,000
﹤0.01% 444
2017
Q2
$11.9M Hold
160,000
﹤0.01% 462
2017
Q1
$15M Buy
+160,000
New +$14.5M ﹤0.01% 437
2015
Q1
Sell
-250,000
Closed -$9.67M 544
2014
Q4
$9.67M Buy
+250,000
New +$7.87M ﹤0.01% 492

Other funds holding NVRO

Capital World Investors's NVRO Position: Q1 2023 in Review

Capital World Investors sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 253,000 shares — an estimated $10M sold.

Capital World Investors first reported a position in NVRO in Q4 2014 and held it in 25 quarters. The position peaked at $41.9M in Q2 2021. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

  • Capital World Investors reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
  • Capital World Investors sold 253,000 NEVRO CORP. shares in Q1 2023, an estimated $10M.
  • Capital World Investors first reported a position in NEVRO CORP. in Q4 2014 and held it in 25 quarters.
  • Capital World Investors's NEVRO CORP. position peaked at $41.9M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.